H.R. 3810 · 118th Congress
Drug Origin Transparency Act of 2023
- Stage
- In committee
- Sponsor
- Anna Eshoo
- Introduced
- 2023-06-05
- Latest action
- 2023-06-09 · Referred to the Subcommittee on Health.
Summary
Drug Origin Transparency Act of 2023
This bill requires drug manufacturers to report on the suppliers of ingredients used in their products.
Specifically, drug manufacturers must report information relating to the supply chain of their products, including the suppliers of active ingredients and the amount of drugs that are manufactured using those ingredients. Drug manufacturers must also include information about the manufacturers of ingredients on the labels of their products.